Inhibition of growth and secreted aspartyl proteinase production in Candida albicans by lysozyme

Journal of Medical Microbiology

Volumn 48, Issue 8, 1999, Pages 721-730

  Wu, T ^a,c   Samaranayake, L P ^a   Leung, W K ^a   Sullivan, P A ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b MASSEY UNIVERSITY   (New Zealand)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ASPARTIC PROTEINASE; LYSOZYME;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; FUNGUS CULTURE; FUNGUS GROWTH; GROWTH INHIBITION; HUMAN; NONHUMAN; PRIORITY JOURNAL;

CANDIDA ALBICANS;

EID: 0032878759     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-48-8-721     Document Type: Article

References (35)

1. 1. Holmstrup P, Samaranayake LP. Acute and AIDS-related oral candidoses. In: Samaranayake LP, MacFarlane TW (eds) Oral candidosis. London, Wright. 1990; 133-155.
2. 2. Samaranayake LP. Oral mycoses in HIV infection. Oral Surg Oral Med Oral Pathol 1992; 73: 171-180.
3. 3. Hube B, Sanglard D, Odds FC et al. Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect Immun 1997; 65: 3529-3538.
4. 4. Sanglard D, Hube B, Monod M, Odds FC, Gow NAR. A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence. Infect Immun 1997; 65: 3539-3546.
5. 5. Morrison CJ, Hurst SF, Bragg SL et al. Heterogeneity of the purified extracellular aspartyl proteinase from Candida albicans: characterization with monoclonal antibodies and N-terminal amino acid sequence analysis. Infect Immun 1993; 61: 2030-2036.
6. 6. White TC, Miyasaki SH, Agabian N. Three distinct secreted aspartyl proteinases in Candida albicans. J Bacteriol 1993; 175: 6126-6133.
7. 7. Monod M, Togni G, Hube B, Sanglard D. Multiplicity of genes encoding secreted aspartic proteinase in Candida species. Mol Microb 1994; 13: 357-368.
8. 8. White TC, Agabian N. Candida albicans secreted aspartyl proteinase: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors. J Bacteriol 1995; 177: 5215-5221.
9. 9. Tenovuo J, Lumikari M, Soukka T. Salivary lysozyme, lactoferrin and peroxidases: antibacterial effects on cariogenic bacteria and clinical applications in preventive dentistry. Proc Finn Dent Soc 1991; 87: 197-208.
10. 10. Ruechel R. Virulence factors of Candida species. In: Samaranayake LP, MacFarlane TW (eds) Oral candidosis. London, Wright. 1990: 47-65.
11. 11. Tobgi ST, Samaranayake LP, MacFarlane TW. The in vitro susceptibility of Candida species to lysozyme. Oral Microbiol Immunol 1987; 2: 1-4.
12. 12. Samaranayake YH, MacFarlane TW, Samaranayake LP, Aitchison T. The in vitro proteolytic and saccharolytic activity of Candida species cultured in human saliva. Oral Microbiol Immunol 1994; 9: 229-235.
13. 13. Germaine GR, Tellefson LM. Effect of pH and human saliva on proteinase production by Candida albicans. Infect Immun 1981; 31: 323-326.
14. 14. Samaranayake LP, Hughes A, MacFarlane TW. The protcolytic potential of Candida alhicans in human saliva supplemented with glucose. J Med Microbiol 1984; 17: 13-22.
15. 15. Mackenzie DWR. Serum tube identification of Candida albicans. J Clin Pathol 1962; 15: 563-565.
16. 16. Angiolella L, De Bernardis F, Bromuro C, Mondello F, Ceddia T, Cassone A. The effect of antimycotics on secretory acid proteinase of Candida albicans. J Chemother 1990; 2: 55-61.
17. 17. De Bernardis F, Agatensi L, Ross IK et al. Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal cardidiasis. J Infect Dis 1990; 161: 1276-1283.
18. 18. Kwong-Chung KJ, Lehman D, Good C, Magee PT. Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect Immun 1985; 49: 571-575.
19. 19. Sprott GD, Koval SF, Schnaitman CA. Cell fractionation. In: Gerhardt P, Murray RGE, Wood WA, Krieg NR (eds) Methods for general molecular bacteriology. Washington, DC, American Society for Microbiology. 1994: 72-103.
20. 20. Kamaya T. Lytic action of lysozyme on Candida albicans. Mycopathol Mycol Appl 1970; 42: 197-207.
21. 21. Marquis G, Montplaisir S, Garzon S, Strykowski H, Auger D. Fungitoxicity of muramidase. Ultrastructural damage to Candida albicans. Lab Invest 1982; 46: 627-636.
22. 22. Imoto T, Johnson LN, North ACT, Philips DC, Rupler JA. Vertebrate lysozymes. In: Boyer PD (ed) The enzymes, 3rd edn. New York, Academic Press. 1972: 665-868.
23. 23. Petit JF, Jollès P. Purification and analysis of human saliva lysozyme. Mature 1963; 200: 168-169.
24. 24. Culter JE. Putative virulence factors of Candida albicans. Anna Rev Microbiol 1991; 45: 187-218.
25. 25. Rüchel R. Properties of a purified proteinase from the yeast Candida albicans. Biochim Biophys Acta 1981; 659: 99-113.
26. 26. Wu I, Samaranayake LP, Cao BY, Wang J. In-vitro proteinase production by oral Candida albicans isolates from individuals with and without HIV infection and its attenuation by antimycotic agents. J Med Microbiol 1996; 44: 311-316.
27. 27. Burgess TL, Kelly RB. Constitutive and regulated secretion of proteins. Annu Rev Cell Biol 1987; 3: 243-249.
28. 28. Homma M, Kanbe T, Chibana H, Tanaka K. Detection of intracellular forms of secretory aspartic proteinase in Candida albicans. J Gen Microbiol 1992; 138: 627-633.
29. 29. Newport G, Agabian N. KEX2 influences Candida albicans proteinase secretion and hyphal formation. J Biol Chem 1997; 272: 28954-28961.
30. 30 Mechler B, Müller M, Müller H, Meussdoerffer F, Wolf DH. In vivo biosynthesis of the vacuolar proteinase A and B in the yeast Saccharomyces cerevisiae. J Biol Chem 1982; 257: 11203-11206.
31. 31. Wright RJ, Came A, Hieber AD, Lamont IL, Emerson GW, Sullivan PA. A second gene for a secreted aspartic proteinase in Candida albicans. J Bacteriol 1992; 174: 7848-7853.
32. 32. Cutfield S, Marshall C, Moody P, Sullivian P, Cutfield J. Crystallization of inhibited aspartic proteinase from Candida albicans. J Mol Biol 1993; 234: 1266-1269.
33. 33. Portillo F, Gancedo C. Purification and properties of three intracellular proteinases from Candida albicans. Biochim Biophys Acta 1986; 881: 229-235.
34. 34. Atkinson JC, Yeh C, Oppenheim FG, Bermudez D, Baum BJ, Fox PC. Elevation of salivary antimicrobial proteins following HIV-1 infection. J Acquir Immune Defic Syndr 1990; 3: 41-48.
35. 35. Mandel ID, Barr CE, Turgeon L. Longitudinal study of parotid saliva in HIV-1 infection. J Oral Pathol Med 1992; 21: 209-213.